Cargando…
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484
Plasminogen activator inhibitor-1 (PAI-1), a key regulator of the fibrinolytic system, is the main physiological inhibitor of plasminogen activators. By interacting with matrix components, including vitronectin (Vn), PAI-1 plays a regulatory role in tissue remodeling, cell migration, and intracellul...
Autores principales: | Sillen, Machteld, Miyata, Toshio, Vaughan, Douglas E., Strelkov, Sergei V., Declerck, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867230/ https://www.ncbi.nlm.nih.gov/pubmed/33540702 http://dx.doi.org/10.3390/ijms22031482 |
Ejemplares similares
-
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
por: Sillen, Machteld, et al.
Publicado: (2020) -
Structural Insights into the Mechanism of a Nanobody That Stabilizes PAI-1 and Modulates Its Activity
por: Sillen, Machteld, et al.
Publicado: (2020) -
Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis
por: Pelisch, Nicolas, et al.
Publicado: (2015) -
A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence
por: Ghosh, Asish K., et al.
Publicado: (2016) -
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021)